No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults.

Wasna Sirirungsi Saik Urien Linda Harrison Jiraporn Kamkon Yardpiroon Tawon Nuananong Luekamlung Suchart Thongpaen Ampaipith Nilmanat Gonzague Jourdain Marc Lallemant Sophie Le Coeur Nicole Ngo-Giang-Huong Andrew Owen Tim R Cressey

J Acquir Immune Defic Syndr

*Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand †EAU08 University Paris Descartes and CIC1419 Inserm, Paris, France ‡Hopital Cochin, Assistance Publique-Hopitaux de Paris, Paris, France §Unite de Recherche clinique, AP-HP, Hopital Tarnier, Paris, France ‖Institut de Recherche pour le Développement (IRD) UMI 174-Program for HIV Prevention and Treatment (PHPT), Marseille, France ¶Lamphun Hospital, Lamphun, Thailand #Maha Sarakham Hospital, Maha Sarakham, Thailand **Hat Yai Hospital, Songkhla, Thailand ††Harvard School of Public Health, Boston, MA ‡‡Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.

Published: April 2015

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334716	PMC
http://dx.doi.org/10.1097/QAI.0000000000000504	DOI Listing

Publication Analysis

Top Keywords

relationship drug

drug transporter

transporter genetic

genetic variants

variants tenofovir

tenofovir plasma

plasma concentrations

concentrations changes

changes glomerular

glomerular filtration

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!